Jatin Patel

Dr. Jatin Patel


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2011 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
JPJatin Patel
Jatin Patel
KLK Landers
K Landers
HLH Li
H Li
RMR H Mortimer
R H Mortimer
KRK Richard
K Richard
The development of fetal thyroid function is dependent on the embryogenesis, differentiation, and maturation of the thyroid gland. This is coupled with evolution of the hypothalamic–pituitary–thyroid axis and thyroid hormone metabolism, resulting in the regulation of thyroid hormone action, production, and secretion. Throughout gestation there is a steady supply of maternal thyroxine (T4) which has been observed in embryonic circulation as early as 4 weeks post-implantation. This is essential for normal early fetal neurogenesis. Triiodothyronine concentrations remain very low during gestation due to metabolism via placental and fetal deiodinase type 3. T4 concentrations are highly regulated to maintain low concentrations, essential for protecting the fetus and reaching key neurological sites such as the cerebral cortex at specific developmental stages. There are many known cell membrane thyroid hormone transporters in fetal brain that play an essential role in regulating thyroid hormone concentrations in key structures. They also provide the route for intracellular thyroid hormone interaction with associated thyroid hormone receptors, which activate their action. There is a growing body of experimental evidence from rats and humans to suggest that even mild maternal hypothyroxinemia may lead to abnormalities in fetal neurological development. Our review will focus on the ontogeny of thyroid hormone in fetal development, with a focus on cell membrane transporters and TR action in the brain.

1 November 2010 in Placenta
Verified
Journal Article
Closed access
JPJatin Patel
Jatin Patel
KLK. Landers
K. Landers
RMR.H. Mortimer
R.H. Mortimer
KRK. Richard
K. Richard

1 May 2011 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
JPJatin Patel
Jatin Patel
KLKelly Landers
Kelly Landers
HLHuika Li
Huika Li
RMRobin H. Mortimer
Robin H. Mortimer
KRKerry Richard
Kerry Richard

1 May 2019 in Cell Reports
Verified
Journal Article
Open access
SLSamuel W. Lukowski
Samuel W. Lukowski
JPJatin Patel
Jatin Patel
SAStacey B. Andersen
Stacey B. Andersen
SSSeen-Ling Sim
Seen-Ling Sim
HWHo Yi Wong
Ho Yi Wong
KKKiarash Khosrotehrani
Kiarash Khosrotehrani
The cellular and molecular profiles that govern the endothelial heterogeneity of the circulatory system have yet to be elucidated. Using a data-driven approach to study the endothelial compartment via single-cell RNA sequencing, we characterized cell subpopulations within and assigned them to a defined endothelial hierarchy. We show that two transcriptionally distinct endothelial populations exist within the aorta and, using two independent trajectory analysis methods, confirm that they represent transitioning cells rather than discrete cell types. Gene co-expression analysis revealed crucial regulatory networks underlying each population, including significant metabolic gene networks in progenitor cells. Using mitochondrial activity assays and phenotyping, we confirm that endovascular progenitors display higher mitochondrial content compared to differentiated endothelial cells. The identities of these populations were further validated against bulk RNA sequencing (RNA-seq) data obtained from normal and tumor-derived vasculature. Our findings validate the heterogeneity of the aortic endothelium and previously suggested hierarchy between progenitor and differentiated cells.

8 October 2013 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
JPJatin Patel
Jatin Patel
ESElke Seppanen
Elke Seppanen
MCMark S.K. Chong
Mark S.K. Chong
JYJulie S.L. Yeo
Julie S.L. Yeo
ETErin Y.L. Teo
Erin Y.L. Teo
KKKiarash Khosrotehrani
Kiarash Khosrotehrani
The term placenta is a highly vascularized tissue and is usually discarded upon birth. Our objective was to isolate clinically relevant quantities of fetal endothelial colony-forming cells (ECFCs) from human term placenta and to compare them to the well-established donor-matched umbilical cord blood (UCB)-derived ECFCs. A sorting strategy was devised to enrich for CD45−CD34+CD31Lo cells prior to primary plating to obtain pure placental ECFCs (PL-ECFCs) upon culture. UCB-ECFCs were derived using a well-described assay. PL-ECFCs were fetal in origin and expressed the same cell surface markers as UCB-ECFCs. Most importantly, a single term placenta could yield as many ECFCs as 27 UCB donors. PL-ECFCs and UCB-ECFCs had similar in vitro and in vivo vessel forming capacities and restored mouse hind limb ischemia in similar proportions. Gene expression profiles were only minimally divergent between PL-ECFCs and UCB-ECFCs, probably reflecting a vascular source versus a circulating source. Finally, PL-ECFCs and UCB-ECFCs displayed similar hierarchies between high and low proliferative colonies. We report a robust strategy to isolate ECFCs from human term placentas based on their cell surface expression. This yielded much larger quantities of ECFCs than UCB, but the cells were comparable in immunophenotype, gene expression, and in vivo functional ability. We conclude that PL-ECFCs have significant bio-banking and clinical translatability potential.

3 January 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
PDPrudence Donovan
Prudence Donovan
JPJatin Patel
Jatin Patel
JDJames Dight
James Dight
HWHo Yi Wong
Ho Yi Wong
SSSeen-Ling Sim
Seen-Ling Sim
KKKiarash Khosrotehrani
Kiarash Khosrotehrani
Tumor vascularization is a hallmark of cancer central to disease progression and metastasis. Current anti-angiogenic therapies have limited success prompting the need to better understand the cellular origin of tumor vessels. Using fate-mapping analysis of endothelial cell populations in melanoma, we report the very early infiltration of endovascular progenitors (EVP) in growing tumors. These cells harbored self-renewal and reactivated the expression of SOX18 transcription factor, initiating a vasculogenic process as single cells, progressing towards a transit amplifying stage and ultimately differentiating into more mature endothelial phenotypes that comprised arterial, venous and lymphatic subtypes within the core of the tumor. Molecular profiling by RNA sequencing of purified endothelial fractions characterized EVPs as quiescent progenitors remodeling the extracellular matrix with significant paracrine activity promoting growth. Functionally, EVPs did not rely on VEGF-A signaling whereas endothelial-specific loss ofRbpjdepleted the population and strongly inhibited metastasis. The understanding of endothelial heterogeneity opens new avenues for more effective anti-vascular therapies in cancer.